Location
United States, North America
Cheque size
$100K - $5M
Investment Stage
Pre Seed
Seed
Focus Areas
Health & Hospital Services
BioTech
Pharmaceuticals
About Investor
Sakae Asanuma is the founding President of Taiho Ventures (San Francisco Bay Area). He backs life science companies, with a tilt toward biotech, pharma, and therapeutics, typically at pre-seed and seed. His usual investment range is $100K – $5.0M. Before Taiho Ventures, he led corporate venture efforts as President/CEO of Astellas Venture Management and headed Astellas innovation in the U.S., with earlier VC experience spanning Japan and the U.S.
Previous investments
Normunity
75M |2025
Anavo Therapeutics
9M |2023
24M |2021
Cellvie
6M |2023
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.